LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2015

Jun 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2015-06-19

Reporting Person: TOMPKINS NICHOLAS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-19	Common Stock	M	5000	$14.56	Acquired	38386	Indirect
2015-06-19	Common Stock	M	2812	$14.56	Disposed	35574	Indirect
2015-06-19	Common Stock	M	5000	$14.56	Acquired	40574	Indirect
2015-06-19	Common Stock	M	2135	$14.56	Disposed	38439	Indirect
2015-06-19	Common Stock	M	5000	$14.56	Acquired	43439	Indirect
2015-06-19	Common Stock	M	1933	$14.56	Disposed	41506	Indirect
2015-06-19	Common Stock	M	5000	$14.56	Acquired	46506	Indirect
2015-06-19	Common Stock	M	1981	$14.56	Disposed	44525	Indirect
2015-06-19	Common Stock	M	5000	$14.56	Acquired	49525	Indirect
2015-06-19	Common Stock	M	2287	$14.56	Disposed	47238	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-19	NonQualified Stock Option (Right to Buy)	$14.56	X	5000	Acquired	2015-07-22	Common Stock (5000)	Direct
2015-06-19	NonQualified Stock Option (Right to Buy)	$14.56	X	5000	Acquired	2016-05-21	Common Stock (5000)	Direct
2015-06-19	NonQualified Stock Option (Right to Buy)	$14.56	X	5000	Acquired	2017-05-26	Common Stock (5000)	Direct
2015-06-19	NonQualified Stock Option (Right to Buy)	$14.56	X	5000	Acquired	2018-05-23	Common Stock (5000)	Direct
2015-06-19	NonQualified Stock Option (Right to Buy)	$14.56	X	5000	Acquired	2019-05-16	Common Stock (5000)	Direct

Footnotes

F1: Mr Tompkins surrendered to the Issuer the right to received an aggregate of 2,812 shares of Common Stock. Mr Tompkins did not sell any shares of Common Stock in connection with the foregoing exercise.

F2: Mr Tompkins surrendered to the Issuer the right to received an aggregate of 2,135 shares of Common Stock. Mr Tompkins did not sell any shares of Common Stock in connection with the foregoing exercise.

F3: Mr Tompkins surrendered to the Issuer the right to received an aggregate of 1,933 shares of Common Stock. Mr Tompkins did not sell any shares of Common Stock in connection with the foregoing exercise.

F4: Mr Tompkins surrendered to the Issuer the right to received an aggregate of 1,981 shares of Common Stock. Mr Tompkins did not sell any shares of Common Stock in connection with the foregoing exercise.

F5: Mr Tompkins surrendered to the Issuer the right to received an aggregate of 2,287 shares of Common Stock. Mr Tompkins did not sell any shares of Common Stock in connection with the foregoing exercise.